Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2

  • Authors:
    • Qiuguo Han
    • Xin Xu
    • Jing Li
    • Jinggang Wang
    • Li Bai
    • Aihong Wang
    • Wei Wang
    • Bo Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Pediatrics, Daqing Oilfield General Hospital, Daqing, Heilongjiang 163000, P.R. China, Department of Pediatric Neurology, The First Hospital of Jilin University, Changchun, Jilin 130000, P.R. China
  • Pages: 6290-6298
    |
    Published online on: August 28, 2017
       https://doi.org/10.3892/mmr.2017.7369
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Members of the GATA‑binding factor protein family, including GATA1, GATA2 and GATA3, serve an inhibiting role in leukemia. The present study demonstrated that GATA4 was upregulated in children with acute lymphoblastic leukemia (ALL). Results from a number of functional experiments, including cell proliferation analysis, cell cycle analysis, cell apoptosis assay and Transwell migration and invasion analyses, have suggested that high expression of GATA4 may facilitate proliferation and metastasis, and suppress apoptosis in ALL cells. Chromatin immunoprecipitation assay and luciferase reporter assay revealed that GATA4 was a transcription factor that activated mouse double minute 2 homolog (MDM2) and B cell lymphoma 2 (BCL2) expression in ALL cells. BCL2 is a key anti‑apoptosis protein that was demonstrated to suppress cell apoptosis. In addition, GATA4 was revealed to regulate p53 through the transcriptional activation of MDM2, subsequently influencing cell cycle and apoptosis. Results from the present study suggested that GATA4 may be a key marker in ALL diagnosis and a potential target of molecular therapy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH and Carroll WL: Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children's oncology group. J Clin Oncol. 30:1663–1669. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Bassan R and Hoelzer D: Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 29:532–543. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Stanulla M and Schrappe M: Treatment of childhood acute lymphoblastic leukemia. Semin Hematol. 46:52–63. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Pui CH, Robison LL and Look AT: Acute lymphoblastic leukaemia. Lancet. 371:1030–1043. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 360:2730–2741. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, et al: A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial. Lancet. 370:240–250. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, et al: Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 41:1006–1010. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, et al: Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 41:1001–1005. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Molkentin JD: The zinc finger-containing transcription factors GATA-4, −5 and −6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem. 275:38949–38952. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Evans T, Reitman M and Felsenfeld G: An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci USA. 85:5976–5980. 1988; View Article : Google Scholar : PubMed/NCBI

11 

Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood. 80:575–581. 1992.PubMed/NCBI

12 

Arceci RJ, King AA, Simon MC, Orkin SH and Wilson DB: Mouse GATA-4: A retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol. 13:2235–2246. 1993. View Article : Google Scholar : PubMed/NCBI

13 

Kelley C, Blumberg H, Zon LI and Evans T: GATA-4 is a novel transcription factor expressed in endocardium of the developing heart. Development. 118:817–827. 1993.PubMed/NCBI

14 

Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS and Wilson DB: Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology. 138:3505–3514. 1997. View Article : Google Scholar : PubMed/NCBI

15 

Vaskivuo TE, Anttonen M, Herva R, Billig H, Dorland M, te Velde ER, Stenbäck F, Heikinheimo M and Tapanainen JS: Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins and transcription factor GATA-4. J Clin Endocrinol Metab. 86:3421–3429. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Kyrönlahti A, Rämö M, Tamminen M, Unkila-Kallio L, Butzow R, Leminen A, Nemer M, Rahman N, Huhtaniemi I, Heikinheimo M and Anttonen M: GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors. Endocrinology. 149:5635–5642. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Jääskeläinen M, Nieminen A, Pökkylä RM, Kauppinen M, Liakka A, Heikinheimo M, Vaskivuo TE, Klefström J and Tapanainen JS: Regulation of cell death in human fetal and adult ovaries-role of Bok and Bcl-X (L). Mol Cell Endocrinol. 330:17–24. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Bergman M and Ringertz N: Gene expression pattern of chicken erythrocyte nuclei in heterokaryons. J Cell Sci. 97:167–175. 1990.PubMed/NCBI

19 

Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S and Toyama K: The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood. 86:3173–3180. 1995.PubMed/NCBI

20 

Ono Y, Fukuhara N and Yoshie O: TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol. 18:6939–6950. 1998. View Article : Google Scholar : PubMed/NCBI

21 

Wang L, Dong L, Liu G, Lin Y, Zhang J, Jia S, Lu S, Pian H, Yao B and Chen H: GATA-2 gene expression in leukemia patients and its significance. Zhonghua Xue Ye Xue Za Zhi. 22:27–29. 2001.(In Chinese). PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM and Liang Q: Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J. 20:800–802. 2006.PubMed/NCBI

24 

Zhang SJ, Shi JY and Li JY: GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. Leuk Res. 33:1141–1143. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Haupt Y, Barak Y and Oren M: Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15:1596–1606. 1996.PubMed/NCBI

26 

Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, et al: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer cell. 1:75–87. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE and Asselin BL: Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 21:3616–3622. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, et al: Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: The FRALLE 93 study. J Clin Oncol. 26:1496–1503. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Wang Z, Kang J, Deng X, Guo B, Wu B and Fan Y: Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro. Oncol Rep. 37:2147–2152. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Walker EM, Thompson CA and Battle MA: GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development. Dev Biol. 392:283–294. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Castro IC, Breiling A, Luetkenhaus K, Ceteci F, Hausmann S, Kress S, Lyko F, Rudel T and Rapp UR: MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma. Mol Cancer Res. 11:161–172. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Anttonen M, Pihlajoki M, Andersson N, Georges A, L'hôte D, Vattulainen S, Färkkilä A, Unkila-Kallio L, Veitia RA and Heikinheimo M: FOXL2, GATA4 and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells. PLoS One. 9:e855452014. View Article : Google Scholar : PubMed/NCBI

33 

Färkkilä A, Andersson N, Bützow R, Leminen A, Heikinheimo M, Anttonen M and Unkila-Kallio L: HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study. Cancer Med. 3:526–536. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Mehta G, Kumarasamy S, Wu J, Walsh A, Liu L, Williams K, Joe B and de la Serna IL: MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy. J Mol Cell Cardiol. 88:101–110. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S and Dirks PB: A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med. 208:689–702. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Soini T, Haveri H, Elo JM, Kauppinen M, Kyrönlahti A, Salo MK, Lohi J, Andersson LC, Wilson DB and Heikinheimo M: Transcription factor GATA-4 is abundantly expressed in childhood but not in adult liver tumors. J Pediatr Gastroenterol Nutr. 54:101–108. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Goldfarb AN: Coordinating red cell differentiation with cell cycle arrest: GATA-1 activation of p21. Cell Cycle. 9:20612010. View Article : Google Scholar : PubMed/NCBI

38 

Papetti M, Wontakal SN, Stopka T and Skoultchi AI: GATA-1 directly regulates p21 gene expression during erythroid differentiation. Cell Cycle. 9:1972–1980. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Ku CJ, Hosoya T, Maillard I and Engel JD: GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood. 119:2242–2251. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Pei Y, Yao Q, Yuan S, Xie B, Liu Y, Ye C and Zhuo H: GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3. Oncotarget. 7:77890–77901. 2016.PubMed/NCBI

41 

Safe S: MicroRNA-specificity protein (sp) transcription factor interactions and significance in carcinogenesis. Curr Pharmacol Rep. 1:73–78. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Han Q, Xu X, Li J, Wang J, Bai L, Wang A, Wang W and Zhang B: GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2. Mol Med Rep 16: 6290-6298, 2017.
APA
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A. ... Zhang, B. (2017). GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2. Molecular Medicine Reports, 16, 6290-6298. https://doi.org/10.3892/mmr.2017.7369
MLA
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A., Wang, W., Zhang, B."GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2". Molecular Medicine Reports 16.5 (2017): 6290-6298.
Chicago
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A., Wang, W., Zhang, B."GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2". Molecular Medicine Reports 16, no. 5 (2017): 6290-6298. https://doi.org/10.3892/mmr.2017.7369
Copy and paste a formatted citation
x
Spandidos Publications style
Han Q, Xu X, Li J, Wang J, Bai L, Wang A, Wang W and Zhang B: GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2. Mol Med Rep 16: 6290-6298, 2017.
APA
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A. ... Zhang, B. (2017). GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2. Molecular Medicine Reports, 16, 6290-6298. https://doi.org/10.3892/mmr.2017.7369
MLA
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A., Wang, W., Zhang, B."GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2". Molecular Medicine Reports 16.5 (2017): 6290-6298.
Chicago
Han, Q., Xu, X., Li, J., Wang, J., Bai, L., Wang, A., Wang, W., Zhang, B."GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2". Molecular Medicine Reports 16, no. 5 (2017): 6290-6298. https://doi.org/10.3892/mmr.2017.7369
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team